Lecanemab: Appropriate Use Recommendations.

•  
• Overview
•  
• Research
•  
• Identity
•  
• Additional Document Info
•  
• View All
•  

Overview

authors

• Cummings, J
• Petersen, R C
• Salloway, S
• Liana Apostolova, MD, MSc, FAAN
• Rabinovici, G D
• Atri, A
• Aisen, P
• Greenberg, S
• Hendrix, S
• Selkoe, D
• Weiner, M

publication date

• 2023

published in

• The journal of prevention of Alzheimer's disease  Journal

has subject area

• Alzheimer Disease
• Amyloid
• Antibodies, Monoclonal
• Antibodies, Monoclonal, Humanized
• Apolipoprotein E4
• Humans

Research

Keywords

• Alzheimer’s disease
• Food and Drug Administration
• accelerated approval
• aducanumab
• amyloid imaging
• amyloid-related imaging abnormalities (ARIA)
• donanemab
• lecanemab
• magnetic resonance imaging (MRI)
• prescribing information

Identity

Digital Object Identifier (DOI)

• https://doi.org/10.14283/jpad.2023.30

PubMed ID

• 37357276

Additional Document Info

start page

• 362

end page

• 377

volume

• 10

issue

• 3